Product
Supplier
Encyclopedia
Inquiry
Home > Encyclopedia > Enzastaurin

Enzastaurin

Enzastaurin structure

Enzastaurin 

structure
  • CAS No:

    170364-57-5

  • Formula:

    C32H29N5O2

  • Chemical Name:

    Enzastaurin

  • Synonyms:

    1H-Pyrrole-2,5-dione,3-(1-methyl-1H-indol-3-yl)-4-[1-[1-(2-pyridinylmethyl)-4-piperidinyl]-1H-indol-3-yl]-;3-(1-Methyl-1H-indol-3-yl)-4-[1-[1-(2-pyridinylmethyl)-4-piperidinyl]-1H-indol-3-yl]-1H-pyrrole-2,5-dione;Enzastaurin;3-(1-Methyl-1H-indol-3-yl)-4-[1-[1-[(pyridin-2-yl)methyl]piperidin-4-yl]-1H-indol-3-yl]pyrrole-2,5-dione;3-(1-Methylindol-3-yl)-4-[1-[1-(pyridin-2-ylmethyl)piperidin-4-yl]indol-3-yl]pyrrole-2,5-dione;DB 102

  • Categories:

    Biochemical Engineering  >  Inhibitors

Description

Enzastaurin is a potent and selective PKCβ inhibitor with an IC50 of 6 nM, showing 6- to 20-fold selectivity over PKCα, PKCγ and PKCε.


3-(1-methyl-3-indolyl)-4-[1-[1-(2-pyridinylmethyl)-4-piperidinyl]-3-indolyl]pyrrole-2,5-dione is a member of indoles and a member of maleimides.|Enzastaurin, an investigational, targeted, oral agent, will be evaluated at more than 100 sites worldwide for the treatment of relapsed glioblastoma multiforme (GBM), an aggressive and malignant form of brain cancer.

Enzastaurin Basic Attributes

515.6

515.60

UC96G28EQF

DTXSID5044029

29339900

Characteristics

72.2

3.7

light orange to dark orange-red

1.34

154-156 °C

767.2±60.0 °C(Predicted)

417.8℃

1.723

DMSO: soluble10mg/mL, clear (warmed)

-20°C

1.87E-23mmHg at 25°C

Safety Information

NONH for all modes of transport

3

22

UX9626850

Xn

P264, P270, P273, P301+P312, P330, P501

H302-H413

Drug Information

Investigated for use/treatment in brain cancer, lymphoma (non-hodgkin's), and lung cancer.

Enzastaurin is an oral serine-threonine kinase inhibitor that is designed to suppress tumor growth through multiple mechanisms. Preclinical data indicate it may reduce the cell's ability to reproduce (cell proliferation), increase the natural death of the tumor cells (apoptosis), and inhibit tumor- induced blood supply (angiogenesis). Enzastaurin has been shown to inhibit signaling through the PKC-B and PI3K/AKT pathways. These pathways have been shown to be activated in a wide variety of cancers. In addition to glioblastoma, enzastaurin is also being studied in multiple other tumor types, including non-Hodgkin's lymphoma, colorectal cancer, non-small cell lung cancer, pancreatic cancer, and mantle cell lymphoma.

enzastaurin

Enzastaurin Use and Manufacturing

PKCβ-selective inhibitor, suppresses angiogenesis.

Computed Properties

Molecular Weight:515.6
XLogP3:3.7
Hydrogen Bond Donor Count:1
Hydrogen Bond Acceptor Count:4
Rotatable Bond Count:5
Exact Mass:515.23212518
Monoisotopic Mass:515.23212518
Topological Polar Surface Area:72.2
Heavy Atom Count:39
Complexity:974
Covalently-Bonded Unit Count:1
Compound Is Canonicalized:Yes

Recommended Suppliers of Enzastaurin

Scan the QR Code to Share

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.